CME Group Inc.

NasdaqGS:CME Rapport sur les actions

Capitalisation boursière : US$81.2b

CME Group Croissance future

Future contrôle des critères 1/6

CME Group devrait augmenter ses bénéfices et son chiffre d'affaires de 3.1% et de 3.4% par an respectivement. Le BPA devrait croître de de 2.9% par an. Le rendement des capitaux propres devrait être 13.4% dans 3 ans.

Informations clés

3.1%

Taux de croissance des bénéfices

2.9%

Taux de croissance du BPA

Capital Markets croissance des bénéfices13.9%
Taux de croissance des recettes3.4%
Rendement futur des capitaux propres13.4%
Couverture par les analystes

Good

Dernière mise à jour29 Oct 2024

Mises à jour récentes de la croissance future

Recent updates

Trade On, Cash In: Why CME Group Is My Pick For Income And Growth

Oct 27

Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

Oct 23
Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

CME Group: An Attractive Business Relatively Out Of Favor

Oct 15

CME Group: An Interesting Option For Every Dividend Investor

Oct 08

CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate

Sep 03

CME Group Has It All - Growth, Dividend Growth, And Value

Aug 26

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

Aug 01

CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

Jul 02
CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

CME Group: FMX Market Entry Poses Real Risk

Jul 01

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Jun 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

May 25

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

May 21
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Gunning For CME's Golden Goose

May 01

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Mar 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

CME Group Is One Of My Favorite High-Yielding Stocks Today

Feb 29

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

Feb 20
CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group: Buying 'The House' Proves A Winning Strategy

Feb 14

CME Group: Uncertainty In The World Equals Higher Revenue Growth

Feb 04

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Dec 27
Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

Nov 14
Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Apr 28
We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:CME - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20266,5433,6884,007N/A11
12/31/20256,2573,5243,828N/A14
12/31/20246,1023,4423,756N/A14
9/30/20246,0343,422N/AN/AN/A
6/30/20245,7883,2623,4923,571N/A
3/31/20245,6163,1573,3633,444N/A
12/31/20235,5693,1863,3773,454N/A
9/30/20235,3383,0113,3113,391N/A
6/30/20235,2282,9423,1083,192N/A
3/31/20235,1042,8283,0783,159N/A
12/31/20225,0092,6572,9663,056N/A
9/30/20224,8332,6332,6502,743N/A
6/30/20224,7152,8892,6162,717N/A
3/31/20224,6572,7452,4772,599N/A
12/31/20214,6902,6172,2752,402N/A
9/30/20214,6302,4352,2252,394N/A
6/30/20214,6001,9201,8882,074N/A
3/31/20214,6031,9132,3782,561N/A
12/31/20204,8842,1052,5182,716N/A
9/30/20204,9112,1512,5812,775N/A
6/30/20205,1092,3753,0713,274N/A
3/31/20205,2002,3862,5212,761N/A
12/31/20194,8682,1172,4272,673N/A
9/30/20194,9592,0332,2292,464N/A
6/30/20194,5881,8082,0272,236N/A
3/31/20194,3771,8602,1372,285N/A
12/31/20184,3091,9622,3242,441N/A
9/30/20183,9734,5162,3012,391N/A
6/30/20183,9594,413N/A2,316N/A
3/31/20183,8244,262N/A2,057N/A
12/31/20173,6454,063N/A1,751N/A
9/30/20173,6581,498N/A1,801N/A
6/30/20173,6091,662N/A1,773N/A
3/31/20173,5901,566N/A1,732N/A
12/31/20163,5951,534N/A1,732N/A
9/30/20163,4961,452N/A1,607N/A
6/30/20163,5051,340N/A1,591N/A
3/31/20163,4181,284N/A1,626N/A
12/31/20153,3271,247N/A1,533N/A
9/30/20153,3541,262N/A1,644N/A
6/30/20153,2661,192N/A1,414N/A
3/31/20153,1781,191N/A1,327N/A
12/31/20143,1131,127N/A1,291N/A
9/30/20142,9581,014N/A1,171N/A
6/30/20142,911960N/A1,066N/A
3/31/20142,9901,008N/A1,268N/A
12/31/20132,931977N/A1,281N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CME ( 3.1% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de CME ( 3.1% par an) devraient croître plus lentement que le marché US ( 15.2% par an).

Croissance élevée des bénéfices: Les bénéfices de CME devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CME ( 3.4% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CME ( 3.4% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de CME devrait être faible dans 3 ans ( 13.4 %).


Découvrir les entreprises en croissance